This website uses cookies to enhance the user experience.
B

BIOTEC MISSIONS AS994 428 004

Research
Limited company
c/o Evolve Akersgata 1-5 0158 OSLO, Norge

BIOTEC MISSIONS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
16 years
since Aug 19, 2009
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
140,513
NOK
Annual total result 2024
100,608
NOK
Total equity 2024
100,583
NOK
Last update: Jun 18, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly
ResignedBoard Member-
Alternate Member-

Others

NameRoleShares
S
SYNEGA REGNSKAP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
100
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
140,513
0
0
6,000
Annual Total Result
100,608
-18,137
-24,195
-11,539
Total assets
124,710
24,102
59,875
103,698
Total liabilities
24,128
24,128
21,550
41,177
Total equity
100,583
-26
38,326
62,521

P&L

Year2024202320222021
Total operating income
140,513
0
0
6,000
Total operating costs
39,904
18,137
30,938
20,649
Operating result
100,608
-18,137
-30,938
-14,649
Financial income/costs
0
0
-81
-146
Profit before tax
100,608
-18,137
-31,019
-14,794
Total tax & extraordinary income/cost
0
0
-6,824
-3,255
Annual Total Result
100,608
-18,137
-24,195
-11,539

Balance overview

Year2024202320222021
Total fixed assets
0
0
20,215
13,391
Total current assets
124,710
24,102
39,660
90,307
Total assets
124,710
24,102
59,875
103,698
Short term debt
24,128
24,128
21,550
41,177
Long term debt
0
0
0
0
Total liabilities
24,128
24,128
21,550
41,177
Contributed capital
100,000
100,000
100,000
100,000
Retained earnings
583
-100,026
-61,674
-37,479
Total equity
100,583
-26
38,326
62,521
Total equity and liabilities
124,710
24,102
59,875
103,698

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology